NT
Healthcare & Life Sciences
NorthSea Therapeutics
Netherlandswww.northseatherapeutics.com
NorthSea Therapeutics is a Healthcare & Life Sciences startup based in the Netherlands, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About NorthSea Therapeutics
NorthSea Therapeutics is a startup based in the Netherlands. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
NorthSea Therapeutics is a clinical-stage biotechnology company developing structurally engineered fatty acids (SEFAs) for the treatment of metabolic, inflammatory, and fibrotic diseases, including NASH, MASH, and intestinal failure-associated liver disease (IFALD).
Explore NorthSea Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.